KIWA BIO-TECH PRODUCTS GROUP CORP Stock-Based Compensation
KIWA BIO-TECH PRODUCTS GROUP CORP reported Stock-Based Compensation of $1.85 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-05-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2020-05-29
- KIWA BIO-TECH PRODUCTS GROUP CORP share-based payment arrangement, noncash expense for the quarter ending 2019-12-31 was $302.04K, a 19.51% decline year-over-year.
- KIWA BIO-TECH PRODUCTS GROUP CORP share-based payment arrangement, noncash expense for the quarter ending 2019-09-30 was $428.95K, a 22.89% decline year-over-year.
- KIWA BIO-TECH PRODUCTS GROUP CORP share-based payment arrangement, noncash expense for the quarter ending 2019-06-30 was $593.05K, a 13.77% decline year-over-year.
- KIWA BIO-TECH PRODUCTS GROUP CORP share-based payment arrangement, noncash expense for the quarter ending 2019-03-31 was $529.66K, a 10.00% decline year-over-year.
- KIWA BIO-TECH PRODUCTS GROUP CORP share-based payment arrangement, noncash expense for fiscal 2019 was $1.85M, a 16.04% decline from fiscal 2018.
- KIWA BIO-TECH PRODUCTS GROUP CORP share-based payment arrangement, noncash expense for fiscal 2018 was $2.21M, a 216.46% increase from fiscal 2017.
- KIWA BIO-TECH PRODUCTS GROUP CORP share-based payment arrangement, noncash expense for fiscal 2017 was $697.67K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $302.04K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-29 | $730.99K derived: sum of 2 quarters · filed 2020-05-29 | $1.32M derived: sum of 3 quarters · filed 2020-05-29 | $1.85M 10-K · filed 2020-05-29 |
| 2019-09-30 | $428.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.02M derived: sum of 2 quarters · filed 2019-11-14 | $1.55M 10-Q · filed 2019-11-14 | $1.93M derived: sum of 4 quarters · filed 2020-05-29 |
| 2019-06-30 | $593.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-19 | $1.12M 10-Q · filed 2019-08-19 | $1.50M derived: sum of 3 quarters · filed 2020-05-29 | $2.05M derived: sum of 4 quarters · filed 2020-05-29 |
| 2019-03-31 | $529.66K 10-Q · filed 2019-05-15 | $904.92K derived: sum of 2 quarters · filed 2020-05-29 | $1.46M derived: sum of 3 quarters · filed 2020-05-29 | $2.15M derived: sum of 4 quarters · filed 2020-05-29 |
| 2018-12-31 | $375.26K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-29 | $931.58K derived: sum of 2 quarters · filed 2020-05-29 | $1.62M derived: sum of 3 quarters · filed 2020-05-29 | $2.21M 10-K · filed 2020-05-29 |
| 2018-09-30 | $556.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.24M derived: sum of 2 quarters · filed 2019-11-14 | $1.83M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $687.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-19 | $1.28M 10-Q · filed 2019-08-19 | ||
| 2018-03-31 | $588.53K 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | $697.67K 10-K · filed 2019-04-12 | |||
| 2017-06-30 | $153.46K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2019-03-18 | $310.51K 10-Q/A · filed 2019-03-18 | ||
| 2017-03-31 | $157.05K 10-Q/A · filed 2019-03-18 |